Disclaimer: The Stem Cell Ophthalmology Treatment Study or SCOTS
is an open label, non-randomized efficacy study and no guarantees of
specific improvements or visual results are being made. Any medical
procedure carries risks as well as potential benefits. The SCOTS study
has different treatment arms and our principle investigator assigns
patients to minimize risk and maximize potential benefit. Depending on
the arm chosen the risk of potential complications has been calculated
to be from approximately 0.0008% to 5%.